+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kidney Cancer"

Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
From
From
Community Oncology Services Global Market Report 2024 - Product Thumbnail Image

Community Oncology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Interventional Oncology Devices Global Market Report 2024 - Product Thumbnail Image

Interventional Oncology Devices Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Oncology Nutrition Global Market Report 2024 - Product Thumbnail Image

Oncology Nutrition Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
From
Interventional Oncology Global Market - Forecast to 2026 - Product Thumbnail Image

Interventional Oncology Global Market - Forecast to 2026

  • Report
  • September 2022
  • 377 Pages
  • Global
From
Global Interventional Oncology Market 2021-2026 - Product Thumbnail Image

Global Interventional Oncology Market 2021-2026

  • Report
  • December 2021
  • 108 Pages
  • Global
From
From
From
Loading Indicator

Kidney cancer, also known as renal cancer, is a type of cancer that originates in the kidneys. It is one of the most common types of cancer in adults, and is typically diagnosed in individuals over the age of 50. Symptoms of kidney cancer can include blood in the urine, pain in the side or lower back, and a lump in the abdomen. Treatment options for kidney cancer include surgery, radiation therapy, and chemotherapy. In the oncology market, kidney cancer is a major area of focus for drug development. Pharmaceutical companies are researching and developing new treatments to improve outcomes for patients with kidney cancer. These treatments include targeted therapies, immunotherapies, and combination therapies. Some companies in the kidney cancer market include Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more